Sökning: WFRF:(Savva A) > (2005-2009) > Monosomy 7 and dele...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04084naa a2200781 4500 | |
001 | oai:DiVA.org:umu-7073 | |
003 | SwePub | |
008 | 080112s2007 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-70732 URI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hasle, Henrik4 aut |
245 | 1 0 | a Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia :b an international retrospective study. |
264 | 1 | c 2007 |
338 | a print2 rdacarrier | |
520 | a Monosomy 7 (-7) and deletion 7q \del(7q)] are rare in childhood acute myeloid leukemia (AML). We retrospectively collected data on 258 children with AML or refractory anemia with excess blasts in transformation (RAEB-T) and -7 or del(7q) with or without other cytogenetic aberrations \+/- other]. Karyotypes included -7 (n = 90), -7 other (n = 82), del(7q) (n = 21), and del(7q) other (n = 65). Complete remission (CR) was achieved in fewer patients with -7 +/- other compared with del(7q) +/- other (61% versus 89%, P < .001). Overall, the 5-year survival rate was 39% (SE, 3%). Survival was superior in del(7q) +/- other compared with -7 +/- other (51% versus 30%, P < .01). Cytogenetic aberrations considered favorable in AML \t(8;21)(q22;q22), inv(16)(p13q22), t(15;17)(q22;q21), t(9;11)(p22;q23)] (n = 24) were strongly associated with del(7q) and a higher 5-year survival rate compared with del(7q) without favorable cytogenetics (75% versus 46%, P = .03). Patients with -7 and inv(3),-5/del(5q), or + 21 had a 5-year survival rate of 5%. Stem cell transplantation analyzed as a time-dependent variable had no impact on overall survival. However, patients not achieving CR had a 31% survival rate after stem cell transplantation. Childhood AML with chromosome 7 aberrations represents a heterogeneous group of disorders with additional cytogenetic aberrations having a major prognostic impact which should be reflected in future risk-group stratification. | |
653 | a Adolescent | |
653 | a Child | |
653 | a Chromosome Aberrations | |
653 | a Chromosomes; Human; Pair 7 | |
653 | a Female | |
653 | a Gene Deletion | |
653 | a Humans | |
653 | a International Cooperation | |
653 | a Leukemia; Myeloid; Acute/*genetics/*mortality | |
653 | a Male | |
653 | a Monosomy | |
653 | a Remission Induction | |
653 | a Retrospective Studies | |
653 | a Stem Cell Transplantation | |
653 | a Translocation; Genetic | |
700 | 1 | a Alonzo, Todd A4 aut |
700 | 1 | a Auvrignon, Anne4 aut |
700 | 1 | a Behar, Catherine4 aut |
700 | 1 | a Chang, Myron4 aut |
700 | 1 | a Creutzig, Ursula4 aut |
700 | 1 | a Fischer, Alexandra4 aut |
700 | 1 | a Forestier, Eriku Umeå universitet,Pediatrik4 aut |
700 | 1 | a Fynn, Alcira4 aut |
700 | 1 | a Haas, Oskar A4 aut |
700 | 1 | a Harbott, Jochen4 aut |
700 | 1 | a Harrison, Christine J4 aut |
700 | 1 | a Heerema, Nyla A4 aut |
700 | 1 | a van den Heuvel-Eibrink, Marry M4 aut |
700 | 1 | a Kaspers, Gertjan J L4 aut |
700 | 1 | a Locatelli, Franco4 aut |
700 | 1 | a Noellke, Peter4 aut |
700 | 1 | a Polychronopoulou, Sophia4 aut |
700 | 1 | a Ravindranath, Yaddanapudi4 aut |
700 | 1 | a Razzouk, Bassem4 aut |
700 | 1 | a Reinhardt, Dirk4 aut |
700 | 1 | a Savva, Natalia N4 aut |
700 | 1 | a Stark, Batia4 aut |
700 | 1 | a Suciu, Stefan4 aut |
700 | 1 | a Tsukimoto, Ichiro4 aut |
700 | 1 | a Webb, David K4 aut |
700 | 1 | a Wojcik, Dorora4 aut |
700 | 1 | a Woods, William G4 aut |
700 | 1 | a Zimmermann, Martin4 aut |
700 | 1 | a Niemeyer, Charlotte M4 aut |
700 | 1 | a Raimondi, Susana C4 aut |
710 | 2 | a Umeå universitetb Pediatrik4 org |
773 | 0 | t Bloodg 109:11, s. 4641-7q 109:11<4641-7x 0006-4971 |
856 | 4 | u http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17299091&dopt=Citation |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-7073 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.